Introduction
Human immunodeficiency virus type 1 (HIV-1) Vpr is a 96 amino acid non-structural protein that is associated with virus particles and can accumulate at the nuclear envelope and in the nucleus of infected cells (1) (2) (3) (4) . The incorporation of Vpr into particles requires a direct interaction with the p6 region of the Gag polyprotein precursor (5, 6) . Several independent biological activities have been attributed to Vpr during the HIV-1 life cycle. First, expression of Vpr alters the cell cycle progression by arresting cells in the G 2 phase (7-10). Second, Vpr influences the reverse transcription process of the viral DNA and this can modulate the in vivo mutation rate of HIV-1 (11,12). Finally, Vpr is required for the infection of nondividing cells, and this requirement is related, at least in part, to its role in the nuclear translocation of the preintegration complex (PIC) containing the viral DNA. Vpr possesses an affinity for the components of the nuclear pore complex (NPC) and it has been proposed that Vpr may facilitate the nuclear translocation of the PIC across the nuclear envelope (4, (13) (14) (15) (16) . Infection of nondividing, terminally differentiated macrophages and resting T cells, represents a viral reservoir in the host which is crucial for subsequent virus spread to lymphoid organs and Thelper lymphocytes, and finally for AIDS pathogenesis (17) . 7 and leucine as reported (5) . Double transformants were patched on the same medium and replica plated on selective medium lacking tryptophan, leucine and histidine for auxotrophy analysis.
In vitro binding assay. The GST-UNG fusions were expressed in E. Coli BL21 cells (Invitrogen) after induction with 0.5 mM isopropyl-1-thio-β-galactopyranoside (IPTG) for 3 h at 30°C. Bacterial pellets were resuspended in phosphate-buffered saline (PBS) containing 2 mM EDTA, 2 mM DTT and an antiprotease cocktail (Sigma). After 1 h incubation at 4 °C with 0.12% lysozyme, bacterial lysis was completed by adding 1% Triton X-100, 10 mM MgCl 2 , 10 µg/ml RNase A and 20 µg/ml DNAse I. Lysates were centrifuged at 60 000 g for 30 min at 4°C. Supernatants were incubated with glutathione-sepharose beads (Amersham Biosciences) for 1 h at 4°C. Beads were washed three times with NaCl 1 M containing 0.5% Triton X-100, and then with PBS. The concentration of the fusion proteins was estimated on a SDS-PAGE gel stained with Coomassie blue G-250 (BioRad) relatively to a range of bovine serum albumin standard. Cell lysates from 6.10 UNG catalytic assay. A catalytic assay was developed to detect the incorporation of UNG into virus particles. Briefly, we cotransfected (Superfect, Qiagen) a vpr-defective HIV-1 vector and Vpr and UNG expression plasmids derived from pAS1B (11) into 293T cells. After 48 h, cell culture supernatants were collected and virions were concentrated by ultracentrifugation as previously described (5) . Virions were resuspended as described (5), and 1 µg of crude viral protein was used in the UNG assay. The DNA oligonucleotide 5'-TTTTTTTTTTTTUTTTTTTTTTTTT-3'used for the UNG assay was chosen based on previous studies (26), and was obtained from Sigma-Genosys (The Woodlands, TX). Uracil-DNA glycosylase inhibitor (UGI) was obtained from New England Biolabs (Beverly, MA). Assays of UNG activity were done with the single-stranded DNA oligonucleotide substrate and were performed in UNG reaction buffer (20 mM Tris-HCl, 1 mM EDTA, 1 mM dithiothreitol pH 8.0) at 37 °C for 1 h. Apurinic (AP) sites were cleaved by adding one-half volume of 0.5 M NaOH and one-half volume of 30 mM EDTA and then boiling for 30 min (27) . Samples were then applied to a non-denaturing 20% polyacrylamide gel with electrophoresis at 60 V for 3.5 h, or were applied to a denaturing 19% polyacrylamide gel and running at 400 V for 2 h. Gels were stained with SYBR Gold (Molecular Probes, Eugene, OR), and nucleic acids were visualized with an ultraviolet transilluminator. 9 Superfect (Qiagen). Infection of HeLa target cells was also done by cocultivation of virusproducing cells with target cells (29) . The protocols for analysis of mutant frequencies have been previously described with minor modifications (12, 28, 30) . Specifically, infected peripheral blood mononuclear cells (PBMCs) and monocytes-derived macrophages (MDMs)
were not placed under drug selection and after purification of proviral DNA with the lac repressor protein, the vector cassette containing the mutation target was PCR amplified prior to analysis of mutant frequencies in E. coli.
Isolation and infection of PBMCs and MDMs. PBMCs from HIV-1 seronegative donors
were isolated by Ficoll-Hypaque density centrifugation. PHA-stimulated cells were plated in RPMI/10% FCS containing 10 U/ml IL-2 and streptomycin (100 µg/ml). Peripheral blood monocytes were isolated from fresh PBMCs by adherence to plastic at 37°C. Following overnight culture, the adherent cells were removed from plates by gentle scraping and residual T-lymphocytes were further depleted using anti-CD2 immunomagnetic beads. Cells were cultured in medium without added growth factors. Mature macrophages were derived by culturing the purified monocytes 7 to 14 days in RPMI/10% FCS without additional cytokines. Cells typically became enlarged or spindle shaped with extended processes.
Virus infection of primary cells was done using virus produced from 293T cells transfected (Superfect, Qiagen) with T-cell tropic or macrophage-tropic HIV-1 molecular clones expressing either wt or mutant Vpr. CAp24 equivalent amounts of virus produced from infected cells was used for infection of primary cells and corresponded to a multiplicity of infection of about 0.05. After overnight incubation at 37°C, the cells were washed twice and placed in either RPMI/10%FCS (macrophages, resting T-cells) or medium supplemented with 10 U/ml IL-2 (stimulated PBMCs/stimulated T-cells). Sampling of cell culture supernatants was done immediately after washing (Day 0) and on subsequent timepoints.
Amounts of CAp24 produced were determined by ELISA.
Results

Characterization of the determinants involved in the interaction between Vpr and UNG2.
Previous studies have established a correlation between the property of Vpr to interact with UNG and to influence the HIV-1 mutation rate (11,24). In particular, a VprW54R variant (see Fig. 1B ), which failed to bind UNG in a yeast two-hybrid assay, also failed to recruit UNG into HIV-1 virions, and was not able to complement a vpr null mutant HIV-1 in a mutation rate assay (11). To further characterize the respective molecular determinants of Vpr and UNG involved in the interaction, we developed an in vitro binding assay using recombinant UNG expressed in E. coli in fusion with the glutathione-S-transferase (GST-UNG). Since it has been reported that Vpr binding is related to the presence of a WxxF motif found within the Cterminal part of UNG2 (a.a. 231-234), a GST-UNGW231A/F234G mutant was included as a control of specificity in this in vitro binding assay. Purified recombinant GST-UNG and GST-UNGW231A/F234G fusions were immobilized on GSH-sepharose beads and then incubated with lysates from cells expressing either HA-tagged wild type (wt) Vpr or VprW54R. Bound proteins were analyzed by Western blotting with anti-HA (Fig 1A) . HA-Vpr specifically bound to GST-UNG, but not to GST alone. In contrast, VprW54R was not retained on GST-UNG, and neither wt Vpr nor VprW54R bound to GST-UNGW231A/F234G. These results were in complete agreement with the yeast two-hybrid data reported in Fig. 1B 
Vpr-UNG and HIV -1 replication in macrophages
to maintain the interaction with UNG, and that the W231xxF234 motif of UNG2 is involved in binding to Vpr.
UNG-associated enzymatic activity is recovered from HIV-1 particles. To determine whether the UNG incorporated into virions was catalytically active, we developed a simple assay for UNG activity using a 25-base T homopolymer oligonucleotide substrate containing a single uracil residue located at position 12 (see Fig. 2A ). In the presence of UNG activity, the uracil residue is excised and leaves the phosphodiester backbone. Heating the sample can destroy the backbone at that position, resulting in a 12-base product that can be visualized on a nondenaturing polyacrylamide gel. UNG activity from purified HIV-1 virions was thus expressing UNG as a fusion to the carboxy-terminus of VprW54R. We previously reported that this Vpr mutant failed to recruit UNG2 into virions, even though it is efficiently incorporated into virions (11). The virion incorporation of the VprW54R-UNG fusion was first analyzed using a packaging assay in which the fusion was expressed in trans in virusproducing cells. 293T cells were cotransfected with the HIV-1 vector lacking the vpr gene in combination with the VprW54R-UNG expression plasmid. Cell-and virion-associated Vpr-UNG fusions were then assayed by immunoblotting (Fig. 3A) . The VprW54R-UNG fusion, as well as the wild type Vpr-UNG fusion used as a control, were well expressed in virus producing cells (upper panels), and both fusions were detected from virions purified from the supernatant of transfected cells (lower panels). Using the same enzymatic assay as described above (see Fig. 2A ), we checked that the VprW54R-UNG and Vpr-UNG fusions incorporated into virions were catalytically active (Fig. 3B) . These results indicate that the Vpr-UNG fusion proteins are efficiently incorporated into HIV-1 particles and retain UNG enzymatic activity.
The Vpr-UNG fusion proteins can influence the HIV-1 mutant frequency. The VprW54R-UNG fusion therefore represents a valuable tool for analyzing the direct contribution of UNG to the modulation of the virus mutation rate. We thus used an HIV-1 mutation rate assay to by guest on http://www.jbc.org/ determine if the Vpr-UNG fusions could complement a vpr-defective HIV-1 for mutant frequencies (11). Briefly, the plasmids for expression of Vpr-UNG fusions were transiently cotransfected with helper packaging plasmids into cells containing a single integrated HIV-1 vector provirus containing the lacZ gene as a mutation target. The viruses produced were then used to infect permissive cells, which allowed for a determination of the virus mutant frequency per round of replication (Fig. 4) . In contrast to the fourfold increase in mutant frequency observed by trans-complementation with the VprW54R mutant, the wild type fusion but also the VprW54R-UNG fusion gave rise to virus mutant frequencies equivalent to that observed by complementation with the wild type Vpr protein. These data show that the VprW54R-UNG fusion can rescue the defective phenotype of VprW54R and modulate HIV-1 mutant frequency as efficiently as Vpr, demonstrating that the recruitment of UNG into virions is directly responsible for this Vpr function.
Recruitment of UNG into virions is essential for efficient replication of HIV-1 in macrophages.
Since data presented here as well as a previous study demonstrate that the recruitment of UNG into HIV-1 virions plays an important role at an early step in HIV-1 replication (e.g., viral DNA synthesis) (11), we tested whether this recruitment had a direct (Fig. 5) . Whereas HIV-1 expressing Vprwt replicated efficiently in MDMs with a rapid increase in CA p24 antigen at 9 days postinfection and peaking at 15 days, HIV-1 expressing VprW54R had a significant replication defect, with only low levels of CA p24 detected 9 days after infection (Fig. 5A) . In contrast, viruses expressing Vprwt or VprW54R both efficiently replicated in PBMCs (Fig. 5B) . In summary, these data show that VprW54R mutation can influence HIV-1 replication in MDMs, and not in PBMCs, indicating that the Vpr-dependant incorporation of UNG is important for virus replication in non-dividing cells.
Influence of Vpr on HIV-1 mutant frequency in monocyte-derived macrophages. Because the replication defect of HIV-1 expressing the VprW54R mutant was specifically apparent in non-dividing cells, we finally analyzed in MDMs the influence of virion-associated UNG on virus mutant frequencies. The same HIV-1 mutation rate assay was used, but viruses containing the lacZα peptide gene as a mutation target were then used to infect MDMs to determine if the VprW54R mutant could complement a vpr-defective HIV-1. As reported in Table 1 , complementation with Vprwt or with the previously characterized VprR90K (32) mutant that efficiently interacts with UNG led to an average mutation frequency (0.006 and 0.007 mutation/cycle, respectively), which is equivalent to that observed when HeLa cells were the targets for infection (see Fig. 4, and (11) ). However, VprW54R as well as the lack of Vpr expression (∆Vpr) led to a 16-18-fold increase in virus mutant frequencies (averages were 0.109 and 0.098, respectively) compared to that observed with Vprwt during infection of MDMs. This increase is about 4-5 times higher than the increase in virus mutant frequencies observed when HeLa cells were used as target cells (11). Again, trans-complementation with either the VprW54R-UNG or Vpr-UNG fusions led to a mutation rate comparable to that or VprW54R and wild type UNG, indicating that the enzymatic activity detected into virus particles is strictly related to the direct interaction that takes place in virusproducing cells between Vpr and UNG. Currently, three distinct cellular partners of Vpr contain a WxxF motif including TFIIB (34), the adenine nucleotide translocator (35) and UNG (20) . The Trp54 residue of HIV-1 is crucial both for binding to UNG and then its recruitment into viral particles (11,32), but does not participate in the interaction of Vpr with the viral Gag precursor in virus-producing cells, which allows for the incorporation of Vpr into virions (5,11). The three-dimensional structure of the complete Vpr polypeptide was recently solved and confirms that Trp54 is localized between the second and third α-helix. This suggests that this residue is easily accessible for protein-protein interactions with UNG (36) , and that substitution of W54 does not modify or alter the overall conformation of the HIV-1 Vpr protein. Indeed, the VprW54R mutant is still able to induce a G2 arrest of the cell cycle (32) and efficiently localizes at the nuclear envelope through interaction with the hCG1 nucleoporin (data not shown, and (4)).
We therefore took advantage of the VprW54R mutant, which failed to incorporate UNG into virions (11), to generate a Vpr-UNG fusion protein that allows for an evaluation of the specific role(s) of UNG recruitment into viral particles on the early steps of HIV-1 infection.
The VprW54R-UNG fusion is efficiently incorporated into virions, and enzymatic assays performed from purified virions show that the UNG fused to VprW54R was still catalytically active. These results confirm that Vpr can efficiently target proteins within HIV-1 particles without affecting the catalytic properties of the cargo (20, (37) (38) (39) . Moreover, the observation that the Vpr-UNG fusions can restore the mutant frequency phenotype indicates that Vpr and the virion-associated UNG are directly responsible for the modulation of the virus mutant HIV-1 and other lentiviruses are unusual among retroviruses in their ability to infect resting or terminally differentiated cells. Vpr from HIV-1 has been related to facilitate nuclear import of the viral DNA in such non-dividing cells (33) . In this report, we have identified that the virion incorporation of UNG via Vpr also contributes to the ability of HIV-1 to replicate in primary macrophages assigning another critical role of Vpr during the viral life cycle. This implies that UNG is a cellular factor that plays an important role in the early steps of the HIV-1 replication cycle (i. e. viral DNA synthesis). In agreement, it has been recently reported that the misincorporation of uracil into minus strand viral DNA affects the initiation of the plus strand DNA synthesis in vitro (40) . These results suggest that UNG is likely recruited into HIV-1 particles to subsequently minimize the detrimental accumulation of uracil into the newly synthesized proviral DNA. While further work is needed to explain the precise by guest on September 1, 2017 http://www.jbc.org/
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mechanism for how UNG catalytic activity may specifically influence HIV-1 replication in macrophages, it is noteworthy that such nondividing cells express low levels of UNG and contain relatively high levels of dUTP (41) . Similarly , most non-primate lentiviruses, such as feline immunodeficiency virus (FIV), caprine-arthritis-encephalitis virus (CAEV) and equine infectious anemia (EIAV), have also developed an efficient strategy to reduce accumulation of uracil into viral DNA. These lentiviruses encode and package a dUTP pyropshophatase (dUTPase) into virus particles (for review, see (19, 41) ), an enzyme that hydrolyzed dUTP to dUMP, and thus maintains a low level of dUTP. Interestingly, replication of FIV, CAEV or EIAV that lack functional dUTPase activity is severely affected in nondividing host cells (e.g., primary macrophages) (42) (43) (44) . Altogether, these results indicate that uracil misincorporation in viral DNA strands during reverse transcription is deleterious for the ongoing steps of the virus life cycle. The presence of a viral dUTPase or a cellular UNG will prevent these detrimental effects for replication of non-primate and primate lentiviruses in macrophages, respectively.
It is intriguing to note that two viral auxiliary proteins from HIV-1, Vpr and Vif, act in the same way to contribute in the fidelity of the synthesis of the viral DNA from the RNA template, but using two different mechanisms. The Vif protein forms a complex with the cellular deaminase APOBEC-3G (CEM15) preventing its encapsidation into virions (45) (46) (47) (48) (49) , while Vpr binds the DNA repair enzyme, UNG, to recruit it into the particles where it could start to exert its activity. It is tempting to speculate that action of both viral proteins may influence the mutation rate during the course of HIV-1 infection, and their balance may play a key role during disease progression in infected individuals. 
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